Benzinga -
- B of A Securities cut the price target for Fox Corporation (NASDAQ: FOXA) from $42 to $34. B of A Securities analyst Jessica Reif Ehrlich downgraded the stock from Buy to Neutral. Fox shares fell 1.8% to $33.03 in pre-market trading.
- Cantor Fitzgerald raised the price target for Orchard Therapeutics plc (NASDAQ: ORTX) from $3 to $15. Cantor Fitzgerald analyst Pete Stavropoulos maintained an Overweight rating. Orchard Therapeutics shares fell 2% to close at $4.81 on Monday.
- Benchmark increased the price target for H World Group Limited (NASDAQ: HTHT) from $45 to $64. Benchmark analyst Fawne Jiang maintained a Buy rating. H World Group shares fell 0.2% to close at $47.38 on Monday.
- Bernstein boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $265 to $300. Bernstein analyst Stacy Rasgon maintained an Outperform rating. NVIDIA shares fell 0.4% to $264.27 in pre-market trading.
- Credit Suisse increased PVH Corp. (NYSE: PVH) price target from $87 to $93. Credit Suisse analyst Michael Binetti maintained an Outperform rating. PVH shares jumped 11.6% to $82.17 in pre-market trading.
- Raymond James raised the price target for Ciena Corporation (NYSE: CIEN) from $58 to $70. Raymond James analyst Simon Leopold upgraded the stock from Outperform to Strong Buy. Ciena shares rose 3.2% to $50.16 in pre-market trading.
- Barclays boosted Carnival Corporation (NYSE: CCL) price target from $12 to $13. Barclays analyst Brandt Montour maintained an Overweight rating. Carnival shares fell 4.8% to close at $8.79 on Monday.
- Keybanc boosted Darden Restaurants, Inc. (NYSE: DRI) price target from $160 to $170. Keybanc analyst Eric Gonzalez maintained an Overweight rating. Darden shares dropped 0.1% to $153.75 in pre-market trading.
- Morgan Stanley cut NIKE, Inc. (NYSE: NKE) price target from $140 to $130. Morgan Stanley analyst Alex Kurtz maintained an Overweight rating. NIKE shares fell 0.1% to $117.75 in pre-market trading.
- Goldman Sachs slashed BioNTech SE (NASDAQ: BNTX) price target from $156 to $140. Goldman Sachs analyst Chris Shibutani maintained a Neutral rating. BioNTech shares fell 0.7% to $122.70 in pre-market trading.
- BMO Capital raised Microsoft Corporation (NASDAQ: MSFT) price target $265 to $305. BMO Capital analyst Ambrish Srivastava maintained a Market Perform. Microsoft shares fell 0.3% to $275.62 in pre-market trading.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.